Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × genexol-PM × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Breast Neoplasms 6 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Peritoneal Neoplasms 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Liver Diseases 1 Hemangiosarcoma 1 Gynecologic Cancer 1 Digestive System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 21 Paclitaxel 20 Cisplatin 17 Cytoreduction Surgical Procedures 16 Oxaliplatin 13 Carboplatin 12 Fluorouracil 9 Bevacizumab 9 Mitomycin 6 Doxorubicin 6 Leucovorin 5 Docetaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Blood Specimen Collection 4 sodium thiosulfate 3 catumaxomab 3 Gemcitabine 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 130-nm albumin-bound paclitaxel 3 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 liposomal doxorubicin 2 Taxes 2 Palliative Care 2 Observation 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03618758 2023-12-05

IPLUS

Seoul National University Bundang Hospital

Phase 1/2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡